Cefprozil detailed information

Cefprozil detailed information

Gene therapy
Clinical data
Pregnancy category	Catagory-B
Routes of administration	ORAL
ATC code	J01DC10 (WHO)
Physiological data
Legal status
Pharmacokinetic data
Bioavailability	95%
Protein binding	36%
Elimination half-life	1.3 hours
Identifiers
IUPAC name 8-[2-amino-2-(4-hydroxyphenyl)-acetyl] amino-7-oxo-4-prop-1-enyl-2-thia-6- azabicyclo [ 4.2.0]oct-4-ene-5-carboxylic acid
CAS Number	92665-29-7
PubChem Template:Abbreviation	5281006
DrugBank	APRD00461
Chemical and physical data
Formula	C18H19N3O5S
Molar mass	389.427 g/mol

WikiDoc Resources for Cefprozil detailed information
Articles
Most recent articles on Cefprozil detailed information Most cited articles on Cefprozil detailed information Review articles on Cefprozil detailed information Articles on Cefprozil detailed information in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Cefprozil detailed information Images of Cefprozil detailed information Photos of Cefprozil detailed information Podcasts & MP3s on Cefprozil detailed information Videos on Cefprozil detailed information
Evidence Based Medicine
Cochrane Collaboration on Cefprozil detailed information Bandolier on Cefprozil detailed information TRIP on Cefprozil detailed information
Clinical Trials
Ongoing Trials on Cefprozil detailed information at Clinical Trials.gov Trial results on Cefprozil detailed information Clinical Trials on Cefprozil detailed information at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Cefprozil detailed information NICE Guidance on Cefprozil detailed information NHS PRODIGY Guidance FDA on Cefprozil detailed information CDC on Cefprozil detailed information
Books
Books on Cefprozil detailed information
News
Cefprozil detailed information in the news Be alerted to news on Cefprozil detailed information News trends on Cefprozil detailed information
Commentary
Blogs on Cefprozil detailed information
Definitions
Definitions of Cefprozil detailed information
Patient Resources / Community
Patient resources on Cefprozil detailed information Discussion groups on Cefprozil detailed information Patient Handouts on Cefprozil detailed information Directions to Hospitals Treating Cefprozil detailed information Risk calculators and risk factors for Cefprozil detailed information
Healthcare Provider Resources
Symptoms of Cefprozil detailed information Causes & Risk Factors for Cefprozil detailed information Diagnostic studies for Cefprozil detailed information Treatment of Cefprozil detailed information
Continuing Medical Education (CME)
CME Programs on Cefprozil detailed information
International
Cefprozil detailed information en Espanol Cefprozil detailed information en Francais
Business
Cefprozil detailed information in the Marketplace Patents on Cefprozil detailed information
Experimental / Informatics
List of terms related to Cefprozil detailed information

Cefprozil, sometimes spelled cefproxil and sold under the brand name Cefzil, is a cephalosporin type antibiotic. In Europe, it is sold by the name Procef. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections. It comes as a tablet and as a liquid suspension.

Although there is a widely quoted cross-allergy risk of 10% between cephalosporins and penicillin, an article in the Journal of Family Practice (February 2006) has shown no increased risk for cross-allergy for cefprozil and several other 2nd generation or later cephalosporins.

External links

• Information about Cefprozil